Orion Oyj Class A · OMXHEX:ORNAV
Orion Oyj Class A — Investor Day (May 2021)
11 slides from Orion Oyj Class A's investor day presentation, May 26, 2021
Slide 1: Welcome – Orion Capital Markets Day 2021
Welcome Orion Capital Markets Day 2021
Slide 2: Agenda
Agenda Theme Presenter Introduction Timo Lappalainen, President & CEO Satu Ahomäki, SVP Commercial Operations Discussion with Niclas Lindstedt, VP Animal Health Creating growth towards 2025 Virve Laitinen, SVP Specialty Products target and beyond 10 min. BREAK at ~14.15 EEST Q&A at 14.25-14.35 EEST
Slide 3: Disclaimer
Disclaimer This presentation contains forward-looking statements which involve risks and uncertainty factors. These statements are not based on historical facts but relate to the Company’s future activities and performance. They include statements about future strategies and anticipated benefits of
Slide 4: Gaining growth and creating value
Gaining growth and creating value Timo Lappalainen, President & CEO
Slide 5: Disclaimer
Disclaimer This presentation contains forward-looking statements which involve risks and uncertainty factors. These statements are not based on historical facts but relate to the Company’s future activities and performance. They include statements about future strategies and anticipated benefits of
Slide 6: 2025 Growth target – key positives and negatives so far
2025 Growth target – key positives and negatives so far Net sales (continued operations) Organic growth in 2018-2020 all units 1 200 Positives 1 000 Own sales in Europe & 800 Southeast Asia 600 400 ODM-109 Biosimilars 200 Negatives Loss of distribution agreement in Animal Health 0 2018 2019 2020 Los
Slide 7: Orion's strategic focus areas and targets
Orion’s strategic focus areas and targets Quality and safety Focus Areas Strong corporate culture of Competitive product portfolio working together Productivity and flexibility Partnerships Growing more rapidly than the growth in Providing new innovative and cost- the market EUR 1.5 billion in 202
Slide 8: Gaining growth, creating value and building the future
Gaining growth, creating value and building the future Grow existing Grow in-organically – Create value – Competences and portfolio – Acquire new sales and Build competitiveness footprint of tomorrow maximize value competences for long term Build clinical Geographical Nubeqa® In-organic growth devel
Slide 9: The estimated average growth of the pharmaceutical market is 3−6% annually
The estimated average growth of the pharmaceutical market is 3−6% annually +3-6% Global market in 2025 +2-5% 14% USD 1 580-1 610 bn Europe, TOP 5 -2-1% 5% USD 215-245 bn +2-5% 39% Japan USD 75-95 bn USA +7-10% 27% USD 605-635 bn Emerging markets USD 415-445 bn Average annual growth 2021-2025 Europe,
Slide 10: Orion's Sustainability Agenda
Orion’s Sustainability Agenda Patient safety and ensuring Responsibility for reliable supply of medications the environment Business ethics and Responsibility for Orionees transparency Orion Corporation Capital Markets Day 26 May 2021 10
Slide 11: Orion Corporation Capital Markets Day
Orion Corporation Capital Markets Day